Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Nature communications·2026
Same author

Loss of Y Chromosome Associates With Lung and Cardiac Dysfunction in COPD.

Comprehensive Physiology·2026
Same author

Association of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET.

International journal of chronic obstructive pulmonary disease·2026
Same author

Comparative metagenomic analysis on COPD and health control samples reveals taxonomic and functional motifs.

Frontiers in microbiology·2025
Same author

Patient-reported outcome measures for use in patients with alpha-1-antitrypsin deficiency: results of a systematic selection process.

BMJ open respiratory research·2025
Same author

Leukocytic ADAM10 and ADAM17 modulate disease severity and systemic outcome in bacterial and viral pneumonia.

The European respiratory journal·2025

Related Experiment Video

Updated: Jun 20, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K

[Update COPD and cardiovascular events].

Maximilian Leitner, Anna Maria Blum, Robert Bals

    Deutsche Medizinische Wochenschrift (1946)
    |February 21, 2025
    PubMed
    Summary

    Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular disease (CVD) frequently coexist, increasing risks. Integrated, personalized therapies are crucial for managing these interconnected conditions and improving patient outcomes.

    Area of Science:

    • Pulmonary Medicine
    • Cardiology
    • Pharmacology

    Background:

    • Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular disease (CVD) share significant pathophysiological links, including inflammation and oxidative stress.
    • Approximately 70% of COPD patients have cardiovascular comorbidities, worsening prognosis and increasing mortality.
    • Acute exacerbations of COPD (AECOPD) heighten the risk of cardiovascular events.

    Purpose of the Study:

    • To review the intricate relationship between COPD and CVD.
    • To discuss the impact of various COPD therapies on cardiovascular outcomes.
    • To emphasize an integrated approach for managing patients with both conditions.

    Main Methods:

    • Literature review of current research on COPD-CVD interactions.

    More Related Videos

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
    04:53

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

    Published on: October 18, 2024

    680
    Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
    04:03

    Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

    Published on: September 27, 2024

    571

    Related Experiment Videos

    Last Updated: Jun 20, 2026

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
    00:07

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

    Published on: August 24, 2019

    9.6K
    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
    04:53

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

    Published on: October 18, 2024

    680
    Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
    04:03

    Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

    Published on: September 27, 2024

    571
  • Analysis of therapeutic strategies for COPD and their cardiovascular implications.
  • Synthesis of evidence regarding guideline-driven, personalized care.

    • Main Results:

    • Shared mechanisms like systemic inflammation and endothelial dysfunction link COPD and CVD.
    • Inhaled corticosteroids (ICS) and triple therapy may reduce mortality in high-risk COPD patients.
    • Beta-blockers, statins, and SGLT-2 inhibitors show potential benefits, warranting further investigation.

    Conclusions:

    • An integrated care model is essential for optimizing treatment of COPD patients with cardiovascular comorbidities.
    • Personalized, guideline-driven therapies can improve quality of life and clinical outcomes.
    • Early screening and risk factor management for CVD in COPD patients are critical.